ESC 365 - Vascular endothelial growth factor-D and mortality in suspected or known coronary heart disease patients with chronic kidney disease: a subanalysis of the ANOX study

ESC Premium Access

Vascular endothelial growth factor-D and mortality in suspected or known coronary heart disease patients with chronic kidney disease: a subanalysis of the ANOX study

Session: Poster Session 6 - Long term prognosis in coronary artery disease

Topic: Comorbidities

Speaker: Doctor H. Wada (Kyoto, JP)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Hiromichi Wada

National Hospital Organization Kyoto Medical Center, Kyoto (Japan)

0 follower

9 more presentations in this session

Association of atherogenic dyslipidemia with cardiovascular outcomes in patients with pre-diabetes and coronary artery disease

Speaker: Doctor Y. Gao (Beijing, CN)

Extremely elevated lipoprotein (a) as an independent risk factor for coronary heart disease in large patient cohort

Speaker: Mr M. Poudel (Bielefeld, DE)

Vascular endothelial growth factor-D and mortality in suspected or known coronary heart disease patients with diabetes: a subanalysis of the ANOX study

Speaker: Miss M. Wada (Kyoto, JP)

The low expression of circulating microRNA-19a represents an additional mortality risk in stable patients with vascular disease.

Speaker: Professor O. Mayer (Pilsen, CZ)

A systematic follow-up strategy after percutaneous coronary intervention based on patient risk profile: the prospective POST-PCI registry

Speaker: Doctor M. Ferlini (Pavia, IT)

Access the full session

Poster Session 6 - Long term prognosis in coronary artery disease

Speakers: Doctor H. Wada, Doctor Y. Gao, Mr M. Poudel, Miss M. Wada, Professor O. Mayer...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources